Navigation Links
Puritan Medical Products Company Launches New Diagnostic Collection and Transport Systems
Date:4/12/2012

GUILFORD, Maine, April 12, 2012 /PRNewswire/ -- Expanding on the proven value of its American-made diagnostic specimen collection devices, Puritan Medical Products Co. LLC launches two liquid-based multipurpose collection and transport systems for diagnostic use through its newly created division, Puritan Diagnostics Company, LLC.

(Photo: http://photos.prnewswire.com/prnh/20120412/NE86837)

Our universal transport media system has recently received 510k approval in the United States, and approval for our Liquid Amies system is pending. Both systems are approved for sale in Europe. Entirely manufactured in Guilford, Maine, these systems are the crucial first step in the diagnosis of bacterial and viral infections and designed to facilitate safe and effective pre-analytical specimen collection and transport to the laboratory.

The Puritan UTM Transport Systems (UTM) contains a multipurpose medium allowing for transport and maintenance of clinically relevant viruses and bacteria at room temperature.  Medical grade plastic components with a leak proof, self-centering cap feature facilitate easy removal and disposal of the swabs.

The Puritan Liquid Amies Transport Systems is a self-contained, ready-to-use multipurpose collection and transport system for aerobes, anaerobes, and fastidious bacteria up to 48 hours at room temperature.  Puritan Liquid Amies is an ideal system designed to accommodate both automation and traditional liquid specimen processing in clinical laboratories, including culturing and gram staining.

Puritan swabs are easy to use, with tips designed in different sizes to accommodate various sampling sites, such as nose, throat, and wounds.   All handles have pre-molded break points for ease of use with our self-centering cap and soon to be available with custom handle imprinting.

Puritan's executive vice president for global sales, Timothy Templet, notes "The new systems are available with our pure non-yellowing, patent-pending flocked swabs which collect and elute the sample into the transport liquid better than most competing swabs."  Templet adds that a major aspect of both new collection systems is "our ability to provide contract manufacturing and work closely with our customers to create custom liquid solutions to meet essential clinical specimen collection and transport needs."

All Puritan Diagnostics Co. products are manufactured at the Guilford, Maine facility, which includes custom media manufacturing and compounding to meet a multitude of customer needs. Research and development product testing, approval and release takes place in house at the company's state-of-the-art microbiology laboratory and conforms to stringent U.S. quality system regulations.

On the web: www.puritanmedproducts.com


'/>"/>
SOURCE Puritan Medical Products Co. LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Puritan Medical Products Introduces New Patent Pending Flocked Swab Technology
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Globus Medical Raises $110 Million in Series E Financing Round
6. Quark Pharmaceuticals Appoints New Chief Medical Officer
7. Boston University Biomedical Engineers Find Chink in Bacterias Armor
8. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
9. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
10. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
11. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... , July 21, 2017 Did you know that PhRMA ... 2016? Or that combined spending on brand medicines, generics and the ... with brands accounting for just half of this (7 percent)? Or ... thirds of the world,s venture capital investments in high-growth biopharmaceutical startups? ... ...
(Date:7/19/2017)... , July 19, 2017  Mako Medical Laboratories partnered ... the Military Family Assistance Fund (MFA) to bring 140 ... to visit with their families one last time before ... coordinate the travel and logistics needed for these soldiers. ... soldiers and their families. We just wish we could ...
(Date:7/15/2017)... Enterin Inc., a Philadelphia -based biotechnology company ... the completion of a $12.7 million Series A financing round. ... as the participation of existing investors. ... of New Ventures III and our current investors, and view ... of our platform technology to transform the course of PD ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... , ... Fresh Wave® IAQ today announced the launch of its innovative ... at the APPA 2017 Annual Conference and Exhibition in Booth #414. , ... the use of harsh chemicals, Fresh Wave IAQ Smoke Away Air & Fabric Liquid ...
(Date:7/21/2017)... ... 2017 , ... The Margarian Law Firm has filed a class action ... for allegedly containing no ginger. Dr. Pepper produces the “Canada Dry” brand of ginger ... alleges Canada Dry Ginger Ale claims on its bottle that it is made from ...
(Date:7/21/2017)... ST. LOUIS, MO (PRWEB) , ... July 21, 2017 , ... ... are born knowing how to tie their shoes,” says Suzanne Tucker, Founder of St. ... created the Time-In Toolkit, which launches on Kickstarter on Monday, July 21st. , ...
(Date:7/21/2017)... TORONTO, ONTARIO, CANADA (PRWEB) , ... July 21, ... ... repair a torn anterior cruciate ligament (ACL) offer patients improved quality of life ... Orthopaedic Society for Sports Medicine’s Annual Meeting in Toronto, Ontario, Canada. The ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... bone marrow cancer that progresses rapidly without treatment. Newly diagnosed patients face intense ... chance of reoccurrence and relapse. With such a challenging diagnosis that requires ...
Breaking Medicine News(10 mins):